Examining the Risk of Serious Infection in Patients with Psoriasis on Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Zenas Z. N. Yiu; Catherine H. Smith; Darren M. Ashcroft; Mark Lunt; Shernaz Walton; Ruth Murphy; Nick J. Reynolds; Anthony D. Ormerod; Christopher E. M. Griffiths; Richard B. Warren

Examining the Risk of Serious Infection in Patients with Psoriasis on Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Zenas Z. N. Yiu, Catherine H. Smith, Darren M. Ashcroft, Mark Lunt, Shernaz Walton, Ruth Murphy, Nick J. Reynolds, Anthony D. Ormerod, Christopher E. M. Griffiths, Richard B. Warren

Dermatology

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	60-60
Journal	PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume	26
Publication status	Published - Aug 2017

Cite this

Yiu, Z. Z. N., Smith, C. H., Ashcroft, D. M., Lunt, M., Walton, S., Murphy, R., Reynolds, N. J., Ormerod, A. D., Griffiths, C. E. M., & Warren, R. B. (2017). Examining the Risk of Serious Infection in Patients with Psoriasis on Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 26, 60-60.

@article{27a44f23677c4f5b88e4b1cc13fade3d,

title = "Examining the Risk of Serious Infection in Patients with Psoriasis on Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)",

author = "Yiu, {Zenas Z. N.} and Smith, {Catherine H.} and Ashcroft, {Darren M.} and Mark Lunt and Shernaz Walton and Ruth Murphy and Reynolds, {Nick J.} and Ormerod, {Anthony D.} and Griffiths, {Christopher E. M.} and Warren, {Richard B.}",

year = "2017",

month = aug,

language = "English",

volume = "26",

pages = "60--60",

journal = "PHARMACOEPIDEMIOLOGY AND DRUG SAFETY",

issn = "1053-8569",

publisher = "John Wiley and Sons Ltd",

}

Yiu, ZZN, Smith, CH, Ashcroft, DM, Lunt, M, Walton, S, Murphy, R, Reynolds, NJ, Ormerod, AD, Griffiths, CEM & Warren, RB 2017, 'Examining the Risk of Serious Infection in Patients with Psoriasis on Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 26, pp. 60-60.

Examining the Risk of Serious Infection in Patients with Psoriasis on Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). / Yiu, Zenas Z. N.; Smith, Catherine H.; Ashcroft, Darren M. et al.
In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 26, 08.2017, p. 60-60.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Examining the Risk of Serious Infection in Patients with Psoriasis on Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

AU - Yiu, Zenas Z. N.

AU - Smith, Catherine H.

AU - Ashcroft, Darren M.

AU - Lunt, Mark

AU - Walton, Shernaz

AU - Murphy, Ruth

AU - Reynolds, Nick J.

AU - Ormerod, Anthony D.

AU - Griffiths, Christopher E. M.

AU - Warren, Richard B.

PY - 2017/8

Y1 - 2017/8

M3 - Meeting Abstract

SN - 1053-8569

VL - 26

SP - 60

EP - 60

JO - PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

JF - PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

ER -